| pubmed-article:20564135 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20564135 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20564135 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:20564135 | lifeskim:mentions | umls-concept:C0019829 | lld:lifeskim |
| pubmed-article:20564135 | lifeskim:mentions | umls-concept:C0544452 | lld:lifeskim |
| pubmed-article:20564135 | lifeskim:mentions | umls-concept:C0733511 | lld:lifeskim |
| pubmed-article:20564135 | lifeskim:mentions | umls-concept:C0680954 | lld:lifeskim |
| pubmed-article:20564135 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:20564135 | pubmed:issue | 16 | lld:pubmed |
| pubmed-article:20564135 | pubmed:dateCreated | 2010-8-10 | lld:pubmed |
| pubmed-article:20564135 | pubmed:abstractText | The majority of patients with Hodgkin lymphoma (HL) achieve disease remission after primary therapy. To the best of the authors' knowledge, no consensus exists for postremission surveillance imaging. | lld:pubmed |
| pubmed-article:20564135 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20564135 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20564135 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:20564135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20564135 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20564135 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:20564135 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:NeubergDonna... | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:YangFengF | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:AquinoSuzanne... | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:HochbergEphra... | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:Van den... | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:LeeAlfred... | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:LacasceAnn... | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:ZuckermanDan... | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:CrowleyDianeD | lld:pubmed |
| pubmed-article:20564135 | pubmed:author | pubmed-author:ToomeyChristi... | lld:pubmed |
| pubmed-article:20564135 | pubmed:copyrightInfo | Copyright (c) 2010 American Cancer Society. | lld:pubmed |
| pubmed-article:20564135 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20564135 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:20564135 | pubmed:volume | 116 | lld:pubmed |
| pubmed-article:20564135 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20564135 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20564135 | pubmed:pagination | 3835-42 | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:meshHeading | pubmed-meshheading:20564135... | lld:pubmed |
| pubmed-article:20564135 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20564135 | pubmed:articleTitle | Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis. | lld:pubmed |
| pubmed-article:20564135 | pubmed:affiliation | Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02114, USA. | lld:pubmed |
| pubmed-article:20564135 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20564135 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
